Skip to main content

Boston Scientific

Medical DevicesFounded 1979
Reviewed by Swet Parvadiya
Company data updated: November 2026

Financial Performance

Boston Scientific Revenue & Financials

Revenue

$14.2B (FY2024)

Market Cap

$115B

Net Income

$1.6B

Employees

48,000

What is Boston Scientific's revenue?

Boston Scientific had $14.2B in revenue for fiscal year 2024, up 11.5% from 2023. Net income was $1.6B.

Latest revenue
$14.2B (FY2024)
Year-over-year
+11.5%
Growth rate (CAGR)
10.6% over 2 years
Peak revenue
$14.2B (FY2024)
Years of data
3
Employees
48,000
How much profit does Boston Scientific make?
Boston Scientific reported net income of $1.6B for fiscal year 2024.
How many employees does Boston Scientific have?
Boston Scientific has about 48,000 employees.

Financial Analysis

Boston Scientific exhibits an exceptional financial profile characterized by high organic top-line compounding, expanding operating leverage, and robust capital generation. In fiscal year 2024, Boston Scientific generated consolidated net sales of $14.24 billion, representing 15.5% reported growth and over 13% organic growth. GAAP net income reached $1.571 billion, with adjusted operating margin expanding to 26.8%. The company generated over $2.4 billion in operating cash flow, maintaining an investment-grade balance sheet with a net debt-to-EBITDA ratio below 2.2x and deploying capital toward strategic growth acquisitions and opportunistic share repurchases.

Revenue Trend Analysis

YoY Change

+11.5%

2-Year CAGR

+10.6%

Peak Year

2024

Trend

Not enough comparable years

Boston Scientific has 3 full fiscal year figures on this page, compounding at +10.6% annually over 2 years. The most recent year saw a 11.5% increase versus the prior year. Annual revenue peaked in fiscal year 2024 at $14.2B. Of 2 comparable year-over-year steps, 2 showed growth and 0 showed a decline.

Annual revenue history

Fiscal YearRevenueNet IncomeYoY Change
FY2024$14.2B$1.6B+11.5%
FY2023$12.8B$1.4B+9.8%
FY2022$11.6B$1.3B—

Click any row to see year details.

Related Companies

Compare Boston Scientific Revenue With Competitors

Keep researching Boston Scientific

Boston Scientific Revenue and Financial FAQ

What was Boston Scientific's latest reported annual revenue?

In its latest audited financial reporting period, Boston Scientific recorded consolidated net revenue of $14.2B, demonstrating durable revenue growth across its primary operating divisions.

How profitable is Boston Scientific?

Boston Scientific generates industry-leading profitability, combining disciplined cost management with high gross margins to deliver substantial net earnings and superior return on equity (ROE) throughout changing economic cycles.

What is Boston Scientific's capital and liquidity position?

Boston Scientific maintains a fortress balance sheet equipped with ample liquid cash reserves, conservative debt leverage, and capital adequacy ratios that provide substantial safety margins above statutory regulatory requirements.

Does Boston Scientific distribute capital to shareholders?

Boston Scientific executes a disciplined capital allocation strategy that balances internal reinvestment into digital innovation and strategic growth with sustainable ordinary dividends and accretive share repurchase programs.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page
CorpDigest. "Boston Scientific Revenue & Financials." CorpDigest, https://corpdigest.com/company/boston-scientific/financials.
Embed this data
<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Boston Scientific reported $14.2B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/boston-scientific/financials" target="_blank" rel="noopener">CorpDigest — Boston Scientific financials</a></div>

Related Financial Audits

Compare revenue, net income, and market cap scale

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.